I'm a bit confused with the timing.
The "program launches in Q4 CY21" ...... so now.
"The pilot is expected to be completed by the end of Q2"
Are they still talking CY?
So it ends in April - June 2022 (Q2CY22)?
Or does it end December 2021 (Q2FY22)?
"Assessment of the pilot is expected in early Q3, FY22"
Assessment occurs before completion?
Is it assessed in Jan-March 2022?
Is this a one quarter program or three?
I guess they're still getting used to reporting in AU and US fiscal years and they mean the review will be finalised in early Q1FY23 or Q3CY22 (July - Sep 2022).
Regardless, if I'm interpreting the dates as they were meant to be reported, the program will generate AU$4M over 3 quarters. Not bad. Will definitely mean ~AU$20M for the December quarter and higher again for the March 2022 4C.
If my interpretation and their description is wrong and this a 3 month program worth AU$4M, then look out Wednesday.
But why confuse things referring to both FY and CY in announcements?
Those above the equator know down here we report as FY.
Despite getting the majority of their earnings from the US, they are listed on the ASX so I hope they can stick to one hemisphere's reporting terms.
I expect it will be made clearer before the market opens.
- Forums
- ASX - By Stock
- Ann: MedAdvisor signs $USD3m digital COVID-19 patient program
I'm a bit confused with the timing. The "program launches in Q4...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDR (ASX) to my watchlist
|
|||||
Last
53.0¢ |
Change
0.055(11.6%) |
Mkt cap ! $286.2M |
Open | High | Low | Value | Volume |
47.5¢ | 53.0¢ | 47.5¢ | $612.3K | 1.208M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 35858 | 52.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
53.0¢ | 121146 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 36833 | 0.520 |
3 | 13034 | 0.515 |
3 | 3534 | 0.510 |
2 | 16000 | 0.505 |
3 | 13961 | 0.500 |
Price($) | Vol. | No. |
---|---|---|
0.530 | 145137 | 6 |
0.535 | 7500 | 1 |
0.540 | 7528 | 2 |
0.545 | 15000 | 1 |
0.550 | 103461 | 5 |
Last trade - 14.12pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
MDR (ASX) Chart |